USE OF MOTHER CELLS AND MOTHER CELLS WITH DEPECTION OF CD6 FOR THE INDUCTION OF TOLERANCE AGAINST ALLOGENIC TRANSPLANTS AND / OR FOR THE TREATMENT OF LEUKEMIA.

摘要

Use of a composition containing stem cells and stem cells with CD6 depletion for the preparation of a pharmaceutical composition for sequential application over time, for the induction of tolerance against allogeneic transplants and / or for the treatment of blood, immunological diseases or carcinogenic, characterized by the fact that first the stem cells are applied and finally the stem cells with CD6 depletion, excluding human embryonic stem cells.